Serum α1-AT Levels and SERPINA1 Molecular Analysis in Breast Cancer: An Experimental and Computational Study
Authors:
- Guadalupe Ávalos-NavarroGuadalupe Ávalos-Navarro
- Luis A. Bautista-HerreraLBLuis A. Bautista-Herrera
- Asbiel Felipe Garibaldi-RíosAGAsbiel Felipe Garibaldi-Ríos
- Ramiro Ramírez-PatiñoRRRamiro Ramírez-Patiño
- Marisol Gutiérrez-GarcíaMGMarisol Gutiérrez-García
- Perla Briseño-ÁlvarezPBPerla Briseño-Álvarez
- Luis Felipe Jave-SuárezLuis Felipe Jave-Suárez
- Emmanuel Reyes-UribeEREmmanuel Reyes-Uribe
- Martha Patricia Gallegos-ArreolaMartha Patricia Gallegos-Arreola
Open Access
Abstract
Background/Objectives: Breast cancer (BC) is a heterogeneous disease with multifactorial origins, including environmental, genetic, and immunological factors. Inflammatory cytokines, such as alpha 1 antitrypsin (α1-AT), are increased in BC and affect physiological and pathological conditions. This study aimed to evaluate the serum levels of α1-AT and perform a computational analysis of SERPINA1 in BC, as well as their association with molecular subtypes and clinical features. Methods: For the experimental analysis, we evaluated 255 women with BC and 53 healthy women (HW) in a cross-sectional study. Molecular subtypes were identified by immunohistochemistry and TNM was used for clinical staging. Soluble levels of α1-AT were quantified by ELISA. Computational analysis of SERPINA1 expression was performed using GEPIA and cBioPortal. Results: α1-AT was increased in BC women versus HW (75.8 ng/mL vs. 532.2 ng/mL). Luminal A had higher concentration (547.5 ng/mL) than Triple Negative (TN) (484.1 ng/mL), but the levels were not associated with clinical stage. The computational analysis showed that SERPINA1 is overexpressed in BC with differential expression among subtypes; its overexpression is associated with a better prognosis, longer disease-free survival, and overall survival. Conclusions: α1-AT levels are increased in women with BC women compared to HW. The Luminal A subtype shows higher soluble protein levels than the TN one. Furthermore, SERPINA1 mRNA overexpression in BC is linked to a protective effect.Keywords
This publication has 76 references indexed in Scilit:
- The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancerJournal of Thrombosis and Thrombolysis, 2023
- Association of the genetic variants (‐794 CATT5‐8 and ‐173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancerJournal of Clinical Laboratory Analysis, 2020
- Lesión hepática inducida por quimioterapia en niñosAnales de Pediatría, 2019
- Evaluation of Alpha 1-Antitrypsin for the Early Diagnosis of Colorectal CancerPathology and Oncology Research, 2019
- Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profileClinical and Experimental Medicine, 2019
- Understanding breast cancer – The long and winding roadBBA Clinical, 2017
- Breast cancer in young women: an overviewUpdates in Surgery, 2017
- Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axisCancer Letters, 2016
- Clinical implications of the intrinsic molecular subtypes of breast cancerThe Breast, 2015
- Alpha 1‐antitrypsin: A novel tumor‐associated antigen identified in patients with early‐stage breast cancerElectrophoresis, 2012